Hanada Syuichi | Pharmaceutical Research Division Welfide Corporation
スポンサーリンク
概要
関連著者
-
Hanada Syuichi
Pharmaceutical Research Division Welfide Corporation
-
Koshiba Hiroshi
Pharmaceutical Research Division Welfide Corporation
-
Koshiba Hiroshi
Safety Evaluation Laboratory The Green Cross Corporation Hyugo Japan
-
Hanada Shuichi
Safety Evaluation Laboratory The Green Cross Corporation Hyugo Japan
-
Irie Hiroyuki
Pharmaceutical Research Division Welfide Corporation
-
Iwai Masakazu
Safety Evaluation Laboratory The Green Cross Corporation
-
Iwai Masakazu
Safety Evaluation Laboratory The Green Cross Corporation Hyugo Japan
-
Koshiba Hiroshi
Safety Evaluation Laboratory, The Green Cross Corporation, Hyugo, Japan
-
Koshiba Hiroshi
Safety Evaluation Laboratories The Green Cross Corporation
-
Iwai Masakazu
Safety Evaluation Laboratory, The Green Cross Corporation
-
KIMURA Kazuyuki
Pharmaceutical Research Division, Welfide Corporation
-
IRIE Hiroyuki
Safety Evaluation Laboratory, Yoshitomi Pharmaceutical Industries, Ltd.
-
Irie Hiroyuki
Safety Evaluation Laboratory Yoshitomi Pharmaceutical Industries Ltd.
-
Naitoh Kazuhide
Pharmaceutical Research Division Welfide Corporation
-
Kimura Kazuyuki
Pharmaceutical Research Division Welfide Corporation
-
Hanada Shuichi
Safety Evaluation Pharmaceutical Research Division Welfide Co.
-
Koyama Mamoru
Pharmaceutical Research Division Welfide Corporation
-
Hanada Syuichi
Safety Evaluation Laboratory, The Green Cross Corporation
-
Hanada Syuichi
Safety Evaluation Laboratory The Green Cross Corporation
-
Kimura Kazuyuki
Safety Evaluation Laboratory, the Green Cross Corporation
-
Naitoh Kazuhide
Safety Evaluation Laboratory, the Green Cross Corporation
-
Hanada Shuichi
Safety Evaluation Drug Development Laboratories Pharmaceutical Research Division Welfide Corporation
-
Kimura Kazuyuki
Safety Evaluation Drug Development Laboratories Pharmaceutical Research Division Welfide Corporation
-
Hanada Shuichi
Pharmaceutical Research Division Yoshitomi Pharmaceutical Industries
-
Shibata Hiroshi
Pharmacology Research Laboratories, Institute for Drug Discovery Research, Astellas Pharmaceutical I
-
NAKAMURA Norifumi
Pharmaceuticals Research Division, Mitsubishi Pharma Corporation
-
Nishizawa Hiroyuki
Safety Evaluation Laboratory, The Green Cross Corporation, Hyugo, Japan
-
Kawabata Yoshiyasu
Safety Evaluation Laboratory, The Green Cross Corporation, Hyugo, Japan
-
Nakamura Norifumi
Pharmaceutical Research Division Welfide Corporation
-
Nishizawa Hiroyuki
Safety Evaluation Laboratory The Green Cross Corporation Hyugo Japan
-
Kawabata Yoshiyasu
Safety Evaluation Laboratory The Green Cross Corporation Hyugo Japan
-
ASAKURA Eiji
Pharmaceutical Research Division, Welfide Corporation
-
NAITO Kazuhide
Pharmaceutical Research Division, Welfide Corporation
-
YAMAUCHI Takeshi
Pharmaceutical Research Division, Welfide Corporation
-
YADA Kouji
Pharmaceutical Research Division, Welfide Corporation
-
HANAMURA Takuji
Pharmaceutical Research Division, Welfide Corporation
-
ABE Syun-ichi
Pharmaceutical Research Division, Welfide Corporation
-
Fukunaga Yuki
Safety Evaluation Laboratory, The Green Cross Corporation
-
Koyama Mamoru
Safety Evaluation Laboratory, The Green Cross Corporation
-
Yada Kouji
Pharmaceutical Research Division Welfide Corporation
-
Asakura Eiji
Pharmaceutical Research Division Welfide Corporation
-
Abe Syun-ichi
Pharmaceutical Research Division Welfide Corporation
-
Hanamura Takuji
Pharmaceutical Research Division Welfide Corporation
-
Fukunaga Yuki
Safety Evaluation Laboratory The Green Cross Corporation
-
Shibata Hiroshi
Pharmaceutical Research Division Welfide Corporation
-
Yamauchi Takeshi
Pharmaceutical Research Division Welfide Corporation
-
Kawabata Yoshiyasu
Safety Evaluation Drug Development Laboratories Pharmaceutical Research Division Welfide Corporation
著作論文
- Mechanism of coma induced by medium-chain triglycerides emulsion in animal
- Effects of Recombinant Human Macrophage Colony-Stimulating Factor on Atherosclerotic Lesions Established in the Aorta of High Cholesterol-Fed Rabbits
- Detection of antigen-specific IgE by enzyme immunoassay (EIA).
- A Discussion on Reduced Cardiotoxicity of Adriamycin-Oxidized Dextran Conjugate (ADM-OXD)
- Changes of Myelotoxicity of Adriamycin by the Conjugation with the High Molecular Weight Compound